On May 13, 2014, Telik, Inc. (NASDAQ:TELK), shares climbed nearly 50 percent in the current trading session following the news that the clinical-stage drug development company has inked a merger deal with MabVax Therapeutics. TELK stock is trading in the range of $1.39 to $2.06. The company has a market capitalization of $8.66 million. Telik, Inc. (NASDAQ:TELK), stock opened today at $1.65 and is currently trading at $1.49. The stock showed a positive weekly performance of 2.90%.
On May 14, 2014, NephroGenex Inc (NASDAQ:NRX), reported financial results for the quarter ended March 31, 2014. Net cash and cash equivalents as of March 31, 2014 were $33.5 million as compared to approximately $2.1 million as of December 31, 2013, reflecting the proceeds raised from the Company’s February IPO. NephroGenex Inc (NASDAQ:NRX), stock opened at $6.30, in current trading session and currently is at $6.29, by losing 2.33%. The 52 week range of $5.00 – $13.00. Company’s market capitalization is $53.81 million.
Agile Therapeutics Inc (NASDAQ:AGRX), major shareholder Care Capital Iii Llc acquired 500,000 shares of Agile Therapeutics stock on the open market in a transaction dated Thursday, May 29th. The stock was purchased at an average price of $6.00 per share, with a total value of $3,000,000.00. Agile Therapeutics Inc (NASDAQ:AGRX), stock is currently trading at $6.50 and currently trading at $6.50. The EPS of the stock is -0.64. Company’s market capitalization is $120.83 million.
Stifel Nicolaus reissued their buy rating on shares of Sophiris Bio Inc (NASDAQ:SPHS), in a research note released on Wednesday morning,StockRatingsNetwork.com reports. They currently have a $7.00 target price on the stock, down from their previous target price of $9.00. Sophiris Bio Inc (NASDAQ:SPHS), stock opened the session at $2.66, and now is at $2.90. The 52 week range of the SPHS stock remained $2.65 – $17.63 and the day range was $2.66 – $2.90.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), announced the appointment of Douglas Williams, Ph.D., to its board of directors. Dr. Williams currently serves as executive vice president, research and development for Biogen Idec Inc. and was previously chief executive officer of ZymoGenetics, Inc. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), stock opened today at $13.68 and is currently trading at $13.89. The stock showed a negative weekly performance of 3.03%.
Leave a Reply